Fatih Mehmet YAZAR, Aykut URFALIOĞLU, Ömer Faruk BORAN, Abdulkadir BAHAR, Hasan DAĞLI, Mehmet GÜL, Fatma İNANÇ TOLUN, Ertan BULBULOGLU

Transplantasyonda koruma solüsyonlarına eklenen P-Coumaric asit ve Ellagic asit etkinliği

AMAÇ: Bu çalışmada, P-kumarik asit ve ellagik asit ile zenginleştirilmiş Wisconsin Üniversitesi (UW) ve histidin-triptofan-ketoglutarat (HTK) koruma solüsyonlarının koruyucu etkinliğininin değerlendirilmesi amaçlanmıştır. MATERYAL ve METOD: Otuz altı Wistar albino erkek sıçan eşit 6ngruba ayrıldı: (Grup 1) UW; (Grup 2) UW + P-coumaric; (Grup 3) UW+Elagic; (Grup 4) HTK;. (Grup 5) HTK + P-Coumaric; (Grup 6) HTK + Elagic. Karaciğer perfüzyonu yapıldıktan sonra 0, 6 ve 12. saatte karaciğer dokusundan ve perfüzyon sıvısından örnekler alındı. Altıncı saatte histopatolojik ve elektron mikroskopik inceleme için KC biyopsileri yapıldı. BULGULAR: P-coumaric asit ile zenginleştirilmiş gruplarda (grup 2 ve grup5) 0. saatte kontrol gruplarına göre yüksek olan antioksidan enzim aktivitelerinin azaldığı ve 6 ve 12. saatte farkın ortadan kalktığı görüldü. Ellagic asit ile zenginleştirilen gruplarda ise en yüksek en yüksek antioksidan enzim aktivitesinin grup 6’da olduğu, gruplar inflamatuar parametreler olan sitokin aktivitesi açısından değerlendirildiğinde antiinflamatuar sitokinler olan IL4 ve IL10 değerinin en yüksek olduğu grubun grup 6 olduğu, grup 3 de de sonuçların grup 6 ile benzer olduğu görüldü. Grup 2 ve grup 5’de ise sonuçların kontrol grubuna göre düşük olmasına rağmen farkın anlamlı olmadığı tespit edildi (P>0.05). İnflamatuar sitokinler olan TNF- α, IL1 ve IL6 açısından en düşük değerlerin grup 3’de olduğu grup 6 daki sonuçların ise grup 3’e göre yüksek olmakla birlikte özellikle IL6 değerleri açısından kontrol grubuna göre anlamlı oranda düşük olduğu görüldü (P

Anahtar Kelimeler:

karaciğer nakli, koruma solüsyonları, histidin-triptofan-ketoglutarat, Wisconsin Üniversitesi solüsyonu, antioksidan, ellagik asit, p-kumarik asit

Efficacy of P-Coumaric acid and Ellagic acid added to preservation solutions in transplantation

OBJECTIVE: In this study, it was aimed to evaluate the protective efficacy of the University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) preservation solutions enriched with P-coumaric acid and ellagic acid. MATERIAL AND METHOD Thirty-six Wistar albino male rats were divided into equal 6ng groups: (Group 1) UW; (Group 2) UW + P-coumaric; (Group 3) UW + Elagic; (Group 4) HTK ;. (Group 5) HTK + P-Coumaric; (Group 6) HTK + Elagic. After the liver perfusion was performed, samples were taken from the liver tissue and perfusion fluid at 0, 6 and 12 hours. At the sixth hour, liver biopsies were performed for histopathological and electron microscopic examination. RESULTS In groups enriched with p-coumaric acid (group 2 and group 5), antioxidant enzyme activities, which were higher than the control groups, were decreased at the 0th hour and the difference disappeared at the 6th and 12th hour. In the groups enriched with Ellagic acid, the highest antioxidant enzyme activity was in group 6, when the groups were evaluated in terms of cytokine activity, which are inflammatory parameters, the group with the highest anti-inflammatory cytokines IL4 and IL10 was found to be in group 6, and in group 3, the results were found with group 6. it was found to be similar. In group 2 and group 5, although the results were lower than the control group, the difference was not significant (P> 0.05). It was observed that the results in group 6, in which the lowest values in terms of inflammatory cytokines TNF-α, IL1 and IL6 were in group 3, were higher than in group 3, but significantly lower than the control group, especially in terms of IL6 values (P

Keywords:

liver transplantation, preservation solution, antioxidant, histidine-tryptophan-ketoglutarate, P-coumaric acid, ellagic acid, solution of university of Wisconsin,

PDF

___

1. Guibert EE, Petrenko AY, Balaban CL, Somov AY, Rodriguez JV, Fuller BJ. Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother. 2011;38:125-142.
2. Mangus RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993;56:1403–9.
3. Mangus RS, Fridell JA, Vianna RM, Milgrom MA, Chestovich P, Chihara RK,et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008;14:365–73.
4. Feng L, Zhao N, Yao X, Sun X, Du L, Diao X, et al. Histidine-tryptophanketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl. 2007;13:1125–36.
5. Akbulut S, Sevmis Ş, Karakayali H, Bayraktar N, Unlukaplan M, Oksuz E, et al. Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions. World J Gastroenterol. 2014;Sep 14;20(34):12292-300.
6. Mathew S, Abraham TE, Zakaria ZA. Reactivity of phenolic compounds towards free radicals under in vitro conditions. J Food Sci Technol. 2015;52:5790–98.
7. Stojković D, Petrovic´ J, Soković M, Glamočlija J, Kukić-Marković J, Petrović S. In situ antioxidant and antimicrobial activities of naturally occuring caffeic acid, p-coumaric acid and rutin, using food systems. J Sci Food Agric. 2013;93(13): 3205-8.
8. Guven M, Yuksel Y, Sehitoglu MH, Tokmak M, Aras AB, Akman T, Golge UH, Goksel F, Karavelioglu E. The effect of coumaric acid on ischemia-reperfusion injury of sciatic nerve in rats. Inflammation. 2015;38(6): 2124-32.
9. Pei K, Ou J, Huang J, Ou S. p-Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities. J Sci Food Agric. 2016;96(9):2952-62.
10. Cheng N, Wu L, Zheng J, Cao W. 2015 Buckwheat Honey Attenuates Carbon Tetrachloride-Induced Liver and DNA Damage in Mice. Evid Based Complement Alternat Med. 2015:987385.
11. García-Niño WR, Zazueta C. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res. 2015;97: 84-103.
12. Zahin M, Ahmad I, Gupta R.C, Aqil F. Punicalagin and ellagic acid demon-strate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts, Biomed Res Int . 2014;2014:467465.
13. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC, et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res. 2005;25(2A):971-9.
14. El-Shitany NA, El-Bastawissy EA, El-desoky K. Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol. 2014;19(2):290-9.
15. Lee JH, Won JH, Choi JM, Cha HH, Jang YJ, Park S, et al. Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways. J Agric Food Chem. 2014;15;62(41):10110-7.
16. Ohkawa H, Ohishi N, Tagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497-500
18. Sinha AK. Colorimetric assay of catalase. Anal Biochem.1972;47(2):389-94.
19. Beutler E, Matsumoto F. Ethnic variation in red cell glutathione peroxidase activity. Blood. 1975 Jul;46(1):103-10.
20. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. 1973 Selenium: biochemical role as a component of glutathione peroxidase. Science. 9;179(4073):588-90.
21. Busuttil RW, De Carlis LG, Mihaylov PV, Gridelli B, Fassati LR, Starzl TE. The first report of orthotopic liver transplantation in the Western world. Am J Transplant.2012;12:1385–7.
22. Müller SA, Mehrabi A, Schmied BM, Welsch T, Fonouni H, Engelmann G, et al. Partial liver transplantation-living donor liver transplantation and split liver transplantation. Nephrol Dial Transplant. 2007;22 Supp l:viii13–viii22.
23. Li W, Meng Z, Liu Y, Patel RP, Lang JD. The hepatoprotective effect of sodium nitrite on cold ischemia-reperfusion injury. J Transplant. 2012;635179.
24. Stahl JE, Kreke JE, Malek FA, Schaefer AJ, Vacanti J. Consequences of coldischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS One.2008;3:e2468.
25. Lynch RJ, Kubus J, Chenault RH, Pelletier SJ, Campbell DA, Englesbe MJ. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant. 2008;8: 567-73
26. Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Cullen J, et al. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live donor liver transplantation. Exp Clin Transplant. 2006;4: 451-7
27. Avolio AW, Agnes S, Nure E, Maria G, Barbarino R, Pepe G, et al. Comparative evaluation of two perfusion solutions for liver preservation and transplantation. Transplant Proc.2006;8:1066–7.
28. Prasanna N, Krishnan DN, Rasool M. 2013 Sodium arsenite-induced cardiotoxicity in rats: protective role of p-coumaric acid, a common dietary polyphenol. Toxicol Mech Methods. 2013;23(4): 255-62.
29. Shiromwar SS, Chidrawar VR. Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats. Pharmacognosy Res. 2011;3(3):214-9.
30. Celik G, Semiz A, Karakurt S, Arslan S, Adali O, Sen A. A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat. Biomed Res Int. 2013;2013:358945.
31. Salem AM, Mohammaden TF, Ali MA, Mohamed EA, Hassan HF. Ellagic and ferulic acids alleviate gamma radiation and aluminium chloride-induced oxidative damage. Life Sci. 2016;1;160:2-11.